Professional background

Dr Tabish Saifee is a consultant neurologist at University College London Hospitals NHS Foundation Trust and London North West University Healthcare NHS Trust.

At National Hospital for Neurology and Neurosurgery, he runs specialist outpatient and inpatient services in movement disorders, including dedicated clinics in tremor, dystonia, Parkinson’s disease and botulinum toxin treatment for movement disorders. He is also the departmental clinical lead for audit.

At London North West University Healthcare NHS Trust, he is clinical director for neurology and neurophysiology, where he leads neurology services across three hospitals and provides specialist and general neurology care across the full spectrum of neurological disorders.

Dr Saifee qualified from University College London Medical School and completed higher specialist training in neurology through the NIHR Academic Clinical Fellowship programme at National Hospital for Neurology and Neurosurgery and Royal Free London NHS Foundation Trust.

He was awarded a Doctoral Research Fellowship from the National Institute for Health and Care Research and completed a PhD at the UCL Queen Square Institute of Neurology, where his doctoral research focused on the clinical and pathophysiological mechanisms of tremor.

Dr Saifee has an active role in undergraduate and postgraduate neurology education and has received multiple teaching awards. He directs several national neurology courses, including the Queen Square PACES course and the Queen Square Leading Edge Neurology course.

He is a member of the Association of British Neurologists and the International Parkinson and Movement Disorder Society, and has served on the Movement Disorders Advisory Group of the Association of British Neurologists. He has advised National Institute for Health and Care Excellence and National Confidential Enquiry into Patient Outcome and Death on national guidance, technology appraisals and audit in movement disorders.

Research interests

Dr Saifee’s research focuses on movement disorders, particularly tremor, dystonia and Parkinson’s disease, spanning clinical phenomenology, neurophysiology, advanced therapeutics and interventional neurology.

He has published more than 65 peer-reviewed papers in international journals, with an H-index of 28, and has authored book chapters and invited reviews in movement disorders and clinical neurology. His work has focused particularly on tremor, dystonia, Parkinson’s disease, functional movement disorders and botulinum toxin therapeutics.

He is chief investigator and principal investigator for multiple commercial and investigator-led clinical studies in movement disorders and Parkinson’s disease, including clinical trials in digital assessment, and novel neuromodulation for movement disorders.

His current research interests include:

  • Tremor phenomenology and neurophysiology
  • Device-based and neuromodulatory therapies for tremor
  • Parkinson’s disease therapeutics
  • Botulinum toxin treatment in movement disorders
  • Digital biomarkers and remote neurological assessment

Publications